Literature DB >> 6973301

Immunosuppressive effects of cyclophosphamide in pigs.

E J Mackie.   

Abstract

Effects of cyclophosphamide (CY) on circulating leukocytes, lymphoid tissues, and antibody response of the pig were examined. Pigs (10 weeks old) were treated with intraperitoneal injections of 30 mg of CY/kg of body weight at 2-day intervals. Three CY injections depressed total leukocyte, neutrophil, and lymphocyte counts. Circulating B-lymphocyte percentages were depleted by 80% and absolute B-lymphocyte counts by 90%. Circulating T-lymphocyte percentages were not affected by CY treatment, but absolute T-cell counts were depressed by 50%. Lymphocytes were depleted from the cortex of the thymus gland and from the spleen and lymph nodes with a preferential effect on B-dependent areas. All these variables were depressed for the duration of CY treatment and had started to return to within normal values by 4 days after the final treatment. Formation of antibodies to sheep erythrocytes was suppressed in CY-treated pigs until 10 days after inoculation (6 days after final CY treatment); the response of control pigs was detectable 4 days after inoculation. The 6 CY treatments prolonged the depression of all the previously mentioned variables.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973301

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Immune cells are required for cutaneous ulceration in a swine model of chancroid.

Authors:  L R San Mateo; K L Toffer; P E Orndorff; T H Kawula
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  The effect of immunosuppression with cyclophosphamide on an experimental porcine enterovirus infection in piglets.

Authors:  J B Derbyshire
Journal:  Can J Comp Med       Date:  1983-04

3.  Neutropenia restores virulence to an attenuated Cu,Zn superoxide dismutase-deficient Haemophilus ducreyi strain in the swine model of chancroid.

Authors:  L R San Mateo; K L Toffer; P E Orndorff; T H Kawula
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.